quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:58·8d
SECFiling
CERo Therapeutics Holdings Inc. logo

SEC Form 10-K filed by CERo Therapeutics Holdings Inc.

CERO· CERo Therapeutics Holdings Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CERO
    CERo Therapeutics Holdings Inc.
    Health Care

Recent analyst ratings

  • Jun 23UpdateD. Boral Capital$30.00

Related

  • INSIDER2d
    SEC Form 4 filed by Francois Eric
  • INSIDER2d
    SEC Form 3 filed by new insider Francois Eric
  • SEC8d
    SEC Form 424B3 filed by CERo Therapeutics Holdings Inc.
  • SEC9d
    SEC Form 424B3 filed by CERo Therapeutics Holdings Inc.
  • SEC9d
    CERo Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities
  • PR10d
    CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial
  • SEC22d
    SEC Form NT 10-K filed by CERo Therapeutics Holdings Inc.
  • PR25d
    CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022